Berahyaluronidase alfa / pembrolizumab Injectable Product
RxNorm 2723758

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2723758 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: berahyaluronidase alfa / pembrolizumab Injectable Product.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCDG
Berahyaluronidase alfa / pembrolizumab Injectable Product
AUI:12999679
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCDGPrescribable

Semantic Clinical Dose Form Group (SCDG):
Berahyaluronidase alfa / pembrolizumab Injectable Product
(Atom ID: 12999679)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
berahyaluronidase alfa / pembrolizumab Injectable Product
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2723758
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12999679
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCDG
Semantic Clinical Dose Form Group (Ingredient + Dose Form Group)
Source Code
2723758
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AVAILABLE STRENGTH
2000 UNT/ML (expressed as berahyaluronidase alfa-pmph) / 165 MG/ML (expressed as pembrolizumab-pmph)
Available drug strengths listed in the order of ingredients from the drug